Ignite Creation Date:
2025-12-24 @ 9:57 PM
Ignite Modification Date:
2025-12-28 @ 4:47 AM
Study NCT ID:
NCT00774332
Status:
UNKNOWN
Last Update Posted:
2008-10-17
First Post:
2008-10-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL
Sponsor:
Cooperative Study Group A for Hematology
Organization:
Study Overview
Official Title:
A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL
Status:
UNKNOWN
Status Verified Date:
2008-10
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL
Detailed Description:
The feasibility will be evaluated in terms of complete remission rate, duration of complete remission, disease-free survival, overall survival, and toxicities.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: